Tumor site: Prostate
Description: Study evaluating a new treatment approach for erectile dysfunction after prostatectomy and/or radiation therapy focusing on rebuilding nerve pathways and connections. This new treatment approach includes encouragement and education for both patients and their partners, plus pelvic floor therapy for the patient.
Tumor site: Lung
Description: Master protocol to evaluate biomarker-driven therapies and immunotherapies in previously treated non-small lung cancer participants.
More info: View more about this trial here.
Tumor site: Breast
Description: Interventional randomized non-inferiority trial comparing overall survival of patients with hormone receptor positive, Her2 negative metastatic breast cancer monitored with serum tumor marker directed disease monitoring versus the usual care.
More info: View more about this trial at clinicaltrials.gov
Tumor site: Lung
Description: Phase II/III trial that compares the effect of adding cemiplimab to docetaxel and ramucirumab versus docetaxel and ramucirumab alone in treating patients with non-small cell lung cancer that is stage IV or that has come back after a period of improvement.
More info: Adding the immunotherapy drug cemiplimab to usual treatment for people with advanced non-small cell lung cancer who had previous treatment with platinum chemotherapy and immunotherapy (an expanded lung-MAP treatment trial) | clinicaltrials.gov